The Outperformers (31-40)
These companies have been ranked based on their stock's excess return over the Sensex for a five-year period
August 22, 2019
Concrete Gains
After consolidating its position in the South and East, Dalmia Bharat is snapping up distressed assets to gain a national footprint
Krishna Gopalan - March 20, 2018
The Experimentalist
Be it a traditional Indian recipe or a continental classic, Piramal Enterprises' Swati Piramal can give it a gourmet spin
Naini Thaker - December 16, 2017
The consumer-buying spree
Large FMCG companies are making expensive acquisitions to buck the slowdown. Will the strategy pay off?
Krishna Gopalan - February 04, 2016
If you've got it, <br> flaunt it </br>
Pharma companies are giving OTC brands a makeover by splurging on advertising
Himanshu Kakkar - September 29, 2015
Ajay Piramal
The Piramal group chairman is a believer in the Gita and for whom equanimity is second nature
Kripa Mahalingam - July 02, 2015
Critical condition
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
Kripa Mahalingam - June 17, 2015